KBS India (530357)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me start with the simple facts. KBS India sells at ₹8.26, the very top of its 52-week range of ₹1.02 to ₹8.26. The market cap is ₹89 Cr. But price is not the same as value. What would I own? A small 'Other Financial Services' company with latest quarterly sales of only ₹1 Cr, and net profit of roughly ₹0 Cr. Sales growth is -6.9%, and reported profit growth is -1,300%. Those are not numbers of a compounder; they are numbers of a business in trouble. I insist on durable competitive advantages. I see no moat here. I also insist on intelligent capital allocation. With ROE at 0.74% and ROCE at 1.36%, shareholders are earning almost nothing on their equity. A 57.12 P/E and 2.50 P/B are prices Mr. Market charges when he believes in a rosy future. The balance sheet shows book value of ₹3.30 per share, so at ₹8.26 I am paying two and a half times tangible book for a business earning less than one percent on equity. There is no dividend yield — zero — to compensate for the wait. The Piotroski score of 3 out of 9 also signals deep fundamental weakness in profitability, leverage, and efficiency. Debt/equity and promoter holding are not available, which leaves too many unanswered questions for a prudent investor. In Graham's terms, every investment should have a margin of safety. Here, the margin of safety is absent; the price already reflects optimistic expectations. I cannot classify this as a wonderful business at a fair price. It is a weak business at a rich price. If a genuine turnaround happens, earnings will have to improve dramatically and be visible in quarterly reports. Until then, this looks more like a speculation than an investment. I would watch from the sidelines.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer